Ira Solomon, M.D., M.P.H.

Vice President, Chief Safety Officer, Johnson and Johnson Innovation

Professional Overview
Ira Solomon, M.D., M.P.H., is a seasoned medical and scientific leader with extensive expertise in drug safety, risk management, and medical affairs. As the Vice President and Chief Safety Officer at Johnson & Johnson Innovation, he plays a pivotal role in ensuring the safety and well-being of patients worldwide.

Experience Summary

Current Role
In his current position, Dr. Solomon is responsible for overseeing the safety profile and risk management strategies for various pharmaceutical products and pipeline assets across Johnson & Johnson's Innovation division. He collaborates closely with cross-functional teams to drive the development and implementation of robust safety protocols, leveraging his deep understanding of pharmacovigilance, benefit-risk assessment, and regulatory affairs.

Career Progression
Prior to his current role, Dr. Solomon held several leadership positions within The Janssen Pharmaceutical Companies of Johnson & Johnson, where he made significant contributions to the company's drug development and safety initiatives. He served as the Compound Development Team Leader for the Pain and Neuroscience therapeutic area, the Therapeutic Area Safety Head for Cardiovascular and Metabolism, and held various roles in medical safety, benefit-risk assessment, and post-marketing surveillance.

Academic Background
Dr. Solomon earned his Doctor of Medicine (M.D.) degree from the NYU Grossman School of Medicine and a Master of Public Health (M.P.H.) in Epidemiology from the Columbia University Mailman School of Public Health. He also completed a course in Evidence-Based Medicine from the University of Oxford.

Areas of Expertise

• Drug safety and pharmacovigilance

• Benefit-risk assessment and risk management

• Medical affairs and regulatory compliance

• Clinical development and trial design

• Cross-functional collaboration and leadership

Professional Impact
Throughout his career, Dr. Solomon has demonstrated a strong commitment to patient safety and has been instrumental in driving the implementation of innovative safety strategies within the pharmaceutical industry. He has contributed to the successful development and commercialization of several groundbreaking treatments, while ensuring the highest standards of safety and quality.

Conclusion
With his extensive medical expertise, robust industry experience, and unwavering dedication to patient welfare, Dr. Ira Solomon is a respected leader in the field of pharmaceutical safety and innovation. In his current role, he continues to drive positive change and make a meaningful impact on the lives of patients worldwide.